comparemela.com

Latest Breaking News On - International psoriasis council - Page 2 : comparemela.com

New Oral IL-23 Receptor Antagonist Peptide Effective in PASI Reduction for Psoriasis

Bio-Thera Announces Positive Results from Phase 3 Trial of Ustekinumab Biosimilar BAT2206

Just more than a month after the FDA approved their first biosimilar to ustekinumab (Stelara), Bio-Thera Solutions announced positive results from their phase 3 trial of BAT2206

A Shift in the Treatment Paradigm of Plaque Psoriasis

Dr Linda Stein Gold discusses the shift in the treatment paradigm in plaque psoriasis.

Efficacy of IL-23 Inhibitors for Plaque Psoriasis

Expert dermatologists review the efficacy of IL-23 inhibitors for plaque psoriasis in the real world, highlighting the opportunity to individualize treatment.

Psoriasis patients contend with lack of awareness, lifestyle choices and insurance cover

Psoriasis patients contend with lack of awareness, lifestyle choices and insurance cover
thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.